{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T01:49:00Z","timestamp":1791596940408,"version":"4.3.4"},"reference-count":44,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2026JJ50091"],"award-info":[{"award-number":["2026JJ50091"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2022M723565"],"award-info":[{"award-number":["2022M723565"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2024T171062"],"award-info":[{"award-number":["2024T171062"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019081","name":"Science and Technology Program of Hunan Province","doi-asserted-by":"publisher","award":["2025RC3057"],"award-info":[{"award-number":["2025RC3057"]}],"id":[{"id":"10.13039\/501100019081","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82203353"],"award-info":[{"award-number":["82203353"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.isci.2026.117317","type":"journal-article","created":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T12:05:02Z","timestamp":1787400302000},"page":"117317","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Oncogenic USP3 promotes hepatocellular carcinoma progression via K11\/K48-specific deubiquitination and stabilization of YAP"],"prefix":"10.1016","volume":"29","author":[{"given":"Yuanhao","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuanxuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongguang","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2181-0841","authenticated-orcid":false,"given":"Yangying","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2026.117317_bib1","first-page":"683","article-title":"Correction to \u201cCancer treatment and survivorship statistics, 2025\u201d","volume":"75","author":"Wagle","year":"2025","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.isci.2026.117317_bib2","first-page":"308","article-title":"Cancer treatment and survivorship statistics, 2025","volume":"75","author":"Wagle","year":"2025","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.isci.2026.117317_bib3","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41392-024-02075-w","article-title":"Hepatocellular carcinoma: signaling pathways and therapeutic advances","volume":"10","author":"Zheng","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.isci.2026.117317_bib4","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S0140-6736(22)01200-4","article-title":"Hepatocellular carcinoma","volume":"400","author":"Vogel","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.isci.2026.117317_bib5","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1097\/HEP.0000000000001233","article-title":"Adjuvant transarterial chemoembolization for hepatocellular carcinoma following curative resection: A randomized, open-label, phase 3 trial","volume":"82","author":"Ma","year":"2025","journal-title":"Hepatology"},{"key":"10.1016\/j.isci.2026.117317_bib6","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1002\/hep.31614","article-title":"Genomic Analysis of Vascular Invasion in HCC Reveals Molecular Drivers and Predictive Biomarkers","volume":"73","author":"Krishnan","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.isci.2026.117317_bib7","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s12943-024-02046-3","article-title":"Ubiquitination and deubiquitination in cancer: from mechanisms to novel therapeutic approaches","volume":"23","author":"Liu","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.isci.2026.117317_bib8","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1186\/s13046-023-02805-y","article-title":"Targeting ubiquitin specific proteases (USPs) in cancer immunotherapy: from basic research to preclinical application","volume":"42","author":"Gao","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.isci.2026.117317_bib9","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70036","article-title":"Deubiquitinases as novel therapeutic targets for diseases","volume":"5","author":"Xian","year":"2024","journal-title":"MedComm"},{"key":"10.1016\/j.isci.2026.117317_bib10","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s12943-020-01262-x","article-title":"The role of ubiquitination and deubiquitination in cancer metabolism","volume":"19","author":"Sun","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.isci.2026.117317_bib11","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1038\/s41418-022-00960-x","article-title":"Prostate-specific oncogene OTUD6A promotes prostatic tumorigenesis via deubiquitinating and stabilizing c-Myc","volume":"29","author":"Peng","year":"2022","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.isci.2026.117317_bib12","doi-asserted-by":"crossref","first-page":"700","DOI":"10.7150\/thno.47800","article-title":"PLAGL2 promotes the proliferation and migration of gastric cancer cells via USP37-mediated deubiquitination of Snail1","volume":"11","author":"Wu","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.isci.2026.117317_bib13","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1007\/s12272-020-01281-8","article-title":"Ubiquitin-proteasome system (UPS) as a target for anticancer treatment","volume":"43","author":"Park","year":"2020","journal-title":"Arch Pharm. Res. (Seoul)"},{"key":"10.1016\/j.isci.2026.117317_bib14","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1007\/s10637-020-00915-4","article-title":"Phase 1 study of the protein deubiquitinase inhibitor VLX1570 in patients with relapsed and\/or refractory multiple myeloma","volume":"38","author":"Rowinsky","year":"2020","journal-title":"Invest. New Drugs"},{"key":"10.1016\/j.isci.2026.117317_bib15","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.semcancer.2020.03.008","article-title":"Dissenting degradation: Deubiquitinases in cell cycle and cancer","volume":"67","author":"Bonacci","year":"2020","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.isci.2026.117317_bib16","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3390\/cells14020069","article-title":"Ubiquitination Enzymes in Cancer, Cancer Immune Evasion, and Potential Therapeutic Opportunities","volume":"14","author":"Awan","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.isci.2026.117317_bib17","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/s41420-024-02010-6","article-title":"Ubiquitin specific peptidase 3: an emerging deubiquitinase that regulates physiology and diseases","volume":"10","author":"Wang","year":"2024","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.isci.2026.117317_bib18","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1111\/cas.16178","article-title":"USP3: Key deubiquitylation enzyme in human diseases","volume":"115","author":"Zhang","year":"2024","journal-title":"Cancer Sci."},{"key":"10.1016\/j.isci.2026.117317_bib19","first-page":"3143","article-title":"USP3 promotes proliferation of non-small cell lung cancer through regulating RBM4","volume":"24","author":"Liao","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.isci.2026.117317_bib20","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1158\/1541-7786.MCR-19-0197","article-title":"Ubiquitin-Specific Protease 3 Promotes Glioblastoma Cell Invasion and Epithelial-Mesenchymal Transition via Stabilizing Snail","volume":"17","author":"Fan","year":"2019","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.isci.2026.117317_bib21","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41419-021-04460-7","article-title":"USP3 promotes gastric cancer progression and metastasis by deubiquitination-dependent COL9A3\/COL6A5 stabilisation","volume":"13","author":"Wu","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.isci.2026.117317_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217244","article-title":"The role of Hippo\/YAP1 in cancer-associated fibroblasts: Literature review and future perspectives","volume":"604","author":"Athavale","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.isci.2026.117317_bib23","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.canlet.2021.03.006","article-title":"Hippo pathway: Regulation, deregulation and potential therapeutic targets in cancer","volume":"507","author":"Mohajan","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.isci.2026.117317_bib24","article-title":"Targeting YAP1 to improve the efficacy of immune checkpoint inhibitors in liver cancer: mechanism and strategy","volume":"15","author":"Gao","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2026.117317_bib25","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s13045-020-01013-x","article-title":"Proteomic signatures of 16 major types of human cancer reveal universal and cancer-type-specific proteins for the identification of potential therapeutic targets","volume":"13","author":"Zhou","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.isci.2026.117317_bib26","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1158\/0008-5472.CAN-23-4034","article-title":"Ku70 Binding to YAP Alters PARP1 Ubiquitination to Regulate Genome Stability and Tumorigenesis","volume":"84","author":"Shu","year":"2024","journal-title":"Cancer Res."},{"key":"10.1016\/j.isci.2026.117317_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.jceh.2024.102406","article-title":"Evolving Global Etiology of Hepatocellular Carcinoma (HCC): Insights and Trends for 2024","volume":"15","author":"Koshy","year":"2025","journal-title":"J. Clin. Exp. Hepatol."},{"key":"10.1016\/j.isci.2026.117317_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26010306","article-title":"NAFLD and NAFLD Related HCC: Emerging Treatments and Clinical Trials","volume":"26","author":"Khare","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.isci.2026.117317_bib29","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1097\/HEP.0000000000000890","article-title":"Alcohol-associated liver cancer","volume":"80","author":"Fu","year":"2024","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"10.1016\/j.isci.2026.117317_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.jceh.2023.06.013","article-title":"NAFLD and NAFLD-related HCC in Asia: Burden and Surveillance","volume":"14","author":"Koh","year":"2024","journal-title":"J. Clin. Exp. Hepatol."},{"key":"10.1016\/j.isci.2026.117317_bib31","doi-asserted-by":"crossref","DOI":"10.3350\/cmh.2024.0824","article-title":"Hepatocellular carcinoma: updates on epidemiology, surveillance, diagnosis and treatment","volume":"31","author":"Hwang","year":"2025","journal-title":"Clin. Mol. Hepatol."},{"key":"10.1016\/j.isci.2026.117317_bib32","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.tibs.2024.06.006","article-title":"UPS-dependent strategies of protein quality control degradation","volume":"49","author":"M\u00fcller","year":"2024","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.isci.2026.117317_bib33","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.molmed.2023.05.006","article-title":"The ubiquitin-proteasome system in breast cancer","volume":"29","author":"Han","year":"2023","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.isci.2026.117317_bib34","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1039\/D4MD00718B","article-title":"Small molecule targeted protein degradation via the UPS: venturing beyond E3 substrate receptors","volume":"16","author":"Guo","year":"2025","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.isci.2026.117317_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106627","article-title":"Advancing targeted protein degradation for metabolic diseases therapy","volume":"188","author":"Zhou","year":"2023","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.isci.2026.117317_bib36","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/s41417-024-00869-2","article-title":"The deubiquitinating enzyme ATXN3 promotes hepatocellular carcinoma progression by stabilizing TAZ","volume":"32","author":"Peng","year":"2025","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.isci.2026.117317_bib37","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/s41419-024-07117-3","article-title":"USP3 promotes DNA damage response and chemotherapy resistance through stabilizing and deubiquitinating SMARCA5 in prostate cancer","volume":"15","author":"Li","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.isci.2026.117317_bib38","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202357828","article-title":"USP3 plays a critical role in the induction of innate immune tolerance","volume":"24","author":"Duan","year":"2023","journal-title":"EMBO Rep."},{"key":"10.1016\/j.isci.2026.117317_bib39","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s13046-023-02694-1","article-title":"CRISPR\/Cas9-based genome-wide screening of the deubiquitinase subfamily identifies USP3 as a protein stabilizer of REST blocking neuronal differentiation and promotes neuroblastoma tumorigenesis","volume":"42","author":"Karapurkar","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.isci.2026.117317_bib40","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1186\/s13046-019-1270-4","article-title":"Ubiquitin-specific protease 3 promotes cell migration and invasion by interacting with and deubiquitinating SUZ12 in gastric cancer","volume":"38","author":"Wu","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.isci.2026.117317_bib41","doi-asserted-by":"crossref","first-page":"667","DOI":"10.2174\/0115665240258296231024112309","article-title":"USP3 inhibition is Active Against Chemo-resistant Hepatocellular Carcinoma Anchorage-independent Growth via Suppressing Wnt\/\u03b2-catenin","volume":"24","author":"Xu","year":"2024","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.isci.2026.117317_bib42","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/s41401-025-01625-4","article-title":"USP3 stabilizes MIC19 by deubiquitination under hypoxic stress and promotes the progression of non-small cell lung cancer","volume":"47","author":"Zhao","year":"2025","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.isci.2026.117317_bib43","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1158\/1078-0432.CCR-19-1515","article-title":"Smoothened Promotes Glioblastoma Radiation Resistance Via Activating USP3-Mediated Claspin Deubiquitination","volume":"26","author":"Tu","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.isci.2026.117317_bib44","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1186\/s12967-022-03306-w","article-title":"Exosome-mediated lncRNA SND1-IT1 from gastric cancer cells enhances malignant transformation of gastric mucosa cells via up-regulating SNAIL1","volume":"20","author":"Jin","year":"2022","journal-title":"J. Transl. Med."}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226026957?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226026957?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:51:44Z","timestamp":1791593504000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004226026957"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":44,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2589004226026957"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2026.117317","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oncogenic USP3 promotes hepatocellular carcinoma progression via K11\/K48-specific deubiquitination and stabilization of YAP","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2026.117317","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117317"}}